Lifen Zhao Selected Research

Lifen Zhao Research Topics

Disease

14	Neoplasms (Cancer) 05/2024 - 01/2016
6	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2016
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2017 - 09/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2016
2	Inflammation (Inflammations) 11/2023 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 01/2017
2	Carcinogenesis 01/2017 - 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Adenocarcinoma of Lung 07/2022
1	Hemorrhagic Cystitis 07/2022
1	Diarrhea 07/2022
1	Hematuria 07/2022
1	Lung Neoplasms (Lung Cancer) 07/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Shock 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Hyperalgesia 11/2019
1	Chronic Pain 11/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2018
1	Pathologic Processes 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Pneumonia (Pneumonitis) 04/2015
1	Fibrosis (Cirrhosis) 04/2015
1	Lung Injury 04/2015
1	Infections 03/2004

Drug/Important Bio-Agent (IBA)

14	MicroRNAs (MicroRNA)IBA 12/2017 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2016
3	Polysaccharides (Glycans)IBA 12/2016 - 03/2016
3	FucosyltransferasesIBA 09/2016 - 01/2016
1	Chimeric Antigen ReceptorsIBA 05/2024
1	Purinergic P2Y ReceptorsIBA 11/2023
1	NucleotidesIBA 11/2023
1	SugarsIBA 11/2023
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	Gefitinib (Iressa)FDA Link 07/2022
1	EnzymesIBA 07/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Interferon Type IIBA 01/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2019
1	Analgesics (Analgesic Drugs)IBA 11/2019
1	Transient Receptor Potential ChannelsIBA 11/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 12/2017
1	beta-Galactoside alpha-2,3-SialyltransferaseIBA 08/2017
1	Imatinib Mesylate (Gleevec)FDA Link 08/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	bcr-abl Fusion ProteinsIBA 01/2017
1	Untranslated RNA (Noncoding RNA)IBA 01/2017
1	SialyltransferasesIBA 12/2016
1	LuciferasesIBA 08/2016
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016
1	pyrazolanthroneIBA 01/2016
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2015
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2015
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2015
1	Conditioned Culture MediaIBA 04/2015
1	CollagenIBA 04/2015

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2017
4	Drug Therapy (Chemotherapy) 05/2024 - 03/2016
1	Immunotherapy 05/2024
1	Nutritional Support (Artificial Feeding) 01/2018
1	Punctures 03/2004
1	Multifetal Pregnancy Reduction 03/2004
1	Induced Abortion (Induced Abortions) 03/2004